Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease

HIGHLIGHTS

  • who: Melpomeni Peppa and colleagues from the Athens University Medical School, Attikon University Hospital, Athens, Greece have published the research work: Lipid Abnormalities and Cardiometabolic Risk in Patients with Overt and Subclinical Thyroid Disease, in the Journal: (JOURNAL) of 17/05/2011
  • what: Thyroid hormones regulate the expression of enzymes involved in all steps of lipid metabolism leading to the development of qualitative and quantitative changes of lipids, in thyroid disease.

SUMMARY

    Thyroid disease, namely hypothyroidism and hyperthyroidism, constitutes the most common endocrine abnormality in recent years, diagnosed either in subclinical . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?